HutchMED (China) LIMITED (HMDCF) Operating income 2016–2025
HutchMED (China) LIMITED (HMDCF) annual operating income history from SEC filings — each fiscal year as reported.
-$39.2MFY2025 · since FY2016: -$46.7M → -$39.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$39.2M | +10.4% |
| FY2024 | -$43.7M | -337.9% |
| FY2023 | $18.4M | +104.5% |
| FY2022 | -$407.7M | -24.2% |
| FY2021 | -$328.3M | -66.9% |
| FY2020 | -$196.7M | -34.3% |
| FY2019 | -$146.4M | -58.0% |
| FY2018 | -$92.6M | -73.4% |
| FY2017 | -$53.4M | -14.4% |
| FY2016 | -$46.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More HMDCF financial trends
HMDCF RevenueHMDCF Net incomeHMDCF Net marginHMDCF Gross profitHMDCF Gross marginHMDCF Operating marginHMDCF Operating cash flowHMDCF Free cash flowHMDCF Capital expendituresHMDCF Return on equityHMDCF Stock buybacksHMDCF Dividends paidHMDCF Total assetsHMDCF Total liabilitiesHMDCF Shareholders’ equityHMDCF overview →